MedPath

Groin Wound Infection Rate Using Prevena Compared to Standard Dressing in Vascular Surgery Patients With High Risk

Not Applicable
Completed
Conditions
Endovascular Procedures
Interventions
Other: Conventional Dressing
Other: Prevena Dressing
Registration Number
NCT03105154
Lead Sponsor
The Cleveland Clinic
Brief Summary

Evaluate wound healing using Prevena compared to standard dressings in high risk patients after vascular surgery.

Detailed Description

Patients submitted to bilateral femoral endarterectomy will have one groin dressed with PrevenaTM and the contralateral one dressed with conventional bandage immediately after suture. Both PrevenaTM and the conventional bandage at the contralateral side will be removed before the patient discharge. Groin wound complications such as deep space infection, cutaneous cellulitis, dehiscence or re-interventions for wound-related complications will be observed in a 30-day evaluation window. This observation will be performed during the patient admission and in the post-operative standard of care visits among the first 30 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • Patients with known bilateral vascular peripheral disease who are being evaluated for possible bilateral femoral endarterectomy
  • Patients with one or more risk factor (diabetes mellitus, Obesity, heavy smoker, immunodeficiency disease, groin reoperation, prosthetic)
  • Patients in follow-up at Clinic in the Vascular Surgery Department
  • Sign of informed consent
  • English speaking
Exclusion Criteria
  • Refusal to participate
  • pregnancy
  • unilateral femoral endarterectomy
  • subjects for whom Prevena IMS is contraindicated

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional DressingConventional DressingGroin dressed with conventional bandage
Prevena DressingPrevena DressingGroin dressed with Prevena
Primary Outcome Measures
NameTimeMethod
% of infection at 30 days30 days

% of wound occurrence in the Prevena treated groin compared to conventional treated groin

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clevealnd Clnic

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath